Syn2bio S.A. (WSE:S2B)

Market Cap	511.53M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	8.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,140
Open	58.08
Previous Close	57.00
Day's Range	56.04 - 58.80
52-Week Range	26.20 - 96.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Syn2bio

Syn2bio S.A. operates as a biotechnology company. It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. It also engages in the research of new pharmaceutical compounds and its further study, registration, and market launch as a medicinal product. Syn2bio S.A. was incorporated in 2025 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2025
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: S2B

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 4, 2026

Data Sources Report a data error